Author:
Ekwunife Obinna I.,O’Mahony James F.,Gerber Grote Andreas,Mosch Christoph,Paeck Tatjana,Lhachimi Stefan K.
Funder
Alexander von Humboldt-Stiftung
Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health,Health Policy,Pharmacology
Reference65 articles.
1. Globocan. GLOBOCAN 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012. International Agency for Research on Cancer. 2012. http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx . Accessed 26 Nov 2014.
2. WHO. Comprehensive Cervical Cancer: a guide to essential practice. Geneva: WHO 2014.
3. Bray F, Loos AH, McCarron P, Weiderpass E, Arbyn M, Moller H, et al. Trends in cervical squamous cell carcinoma incidence in 13 European countries: changing risk and the effects of screening. Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol. 2005;14(3):677–86. doi: 10.1158/1055-9965.epi-04-0569 .
4. Ferko N, Postma M, Gallivan S, Kruzikas D, Drummond M. Evolution of the health economics of cervical cancer vaccination. Vaccine. 2008;26(Suppl 5):F3–15. doi: 10.1016/j.vaccine.2008.02.004 .
5. WHO. Human papillomavirus vaccines. WHO position paper. Weekly Epidemiological Record. 2009.
Cited by
25 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献